Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SAN DIEGO, CA--(Marketwired - Feb 28, 2017) - Invivoscribe(R) Technologies Inc., una empresa global con más de 20 años de experiencia en soluciones de pruebas de clonalidad y...
-
SAN DIEGO, CA--(Marketwired - Feb 28, 2017) - A Invivoscribe(R) Technologies Inc., uma empresa global com mais de 20 anos de experiência com fornecimento de soluções de testes de...
-
SAN DIEGO, CA--(Marketwired - Feb 28, 2017) - Invivoscribe® Technologies Inc., a global company with more than 20 years of experience providing clonality and biomarker test solutions for the...
-
SAN JOSÉ, CA--(Marketwired - Feb 14, 2017) - Invivoscribe(R) Technologies Inc., una compañía internacional con décadas de experiencia ofreciendo soluciones de pruebas de...
-
SAN DIEGO, CA--(Marketwired - Feb 14, 2017) - A Invivoscribe(R) Technologies Inc., uma empresa global com mais de 20 anos de experiência com fornecimento de soluções para testes de...
-
SAN DIEGO, CA--(Marketwired - Feb 14, 2017) - Invivoscribe® Technologies Inc., an international company with decades of experience providing clonality and biomarker test solutions for the...
-
SAN JOSÉ, CA--(Marketwired - Jan 31, 2017) - Invivoscribe(R) Technologies Inc., una compañía global con más de 20 años de experiencia ofreciendo soluciones de pruebas de...
-
SAN DIEGO, CA--(Marketwired - Jan 31, 2017) - A Invivoscribe(R) Technologies Inc., uma empresa global com mais de 20 anos de experiência com fornecimento de soluções para testes de...
-
SAN DIEGO, CA--(Marketwired - Jan 31, 2017) - Invivoscribe® Technologies Inc., a global company with more than 20 years of experience providing clonality and biomarker test solutions for the...
-
Priority Review based on data from the largest clinical trials conducted to date in each indication[1],[2] Designation will shorten FDA expected review time to within six months[3]; EMA also...